H19 and Sepsis: H19 acted as a competitive endogenous RNA (ceRNA) for AQP1 by regulating miR-874, reversing LPS-induced inflammatory responses and myocardial dysfunction, suggesting H19 as a potential therapeutic target for sepsis-associated myocardial dysfunction (54).